News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Raises £1.03m ($1.6m) in Additional Capital from Existing Investors Imperial Innovations, Longbow Capital and Others


11/16/2010 10:52:41 AM

LONDON--(BUSINESS WIRE)--RepRegenTM Ltd the ‘smart biomaterials’ company, announced today that it has raised £1.03 million ($1.6 million). The financing was led by existing investor Imperial Innovations and included Longbow Capital and other investors. Proceeds will be used to further the product development pipeline: including regulatory approvals, commercialization programs and preparation for relevant post market clinical studies.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES